Geode Capital Management LLC Buys 7,972 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Geode Capital Management LLC increased its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 2.1% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 391,492 shares of the company’s stock after acquiring an additional 7,972 shares during the period. Geode Capital Management LLC’s holdings in OrthoPediatrics were worth $10,615,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of KIDS. Divisadero Street Capital Management LP bought a new position in OrthoPediatrics during the 2nd quarter valued at about $514,000. Wellington Management Group LLP boosted its position in OrthoPediatrics by 16.2% in the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after buying an additional 122,846 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in OrthoPediatrics by 268.1% during the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock worth $6,692,000 after buying an additional 179,803 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after buying an additional 966 shares in the last quarter. Finally, Sei Investments Co. raised its stake in shares of OrthoPediatrics by 345.2% in the second quarter. Sei Investments Co. now owns 30,747 shares of the company’s stock valued at $884,000 after acquiring an additional 23,841 shares during the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Stock Up 2.7 %

NASDAQ:KIDS opened at $23.18 on Wednesday. The company has a market cap of $561.33 million, a price-to-earnings ratio of -18.85 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The stock’s fifty day moving average price is $24.68 and its two-hundred day moving average price is $27.73. OrthoPediatrics Corp. has a 52-week low of $21.02 and a 52-week high of $35.99.

Analyst Ratings Changes

A number of research firms recently weighed in on KIDS. Truist Financial dropped their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. JMP Securities restated a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research report on Friday, November 8th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.